Hoosier Cancer Research Network

What Hoosier Cancer Research Network does

Hoosier Cancer Research Network (HCRN) is an Indianapolis-based nonprofit contract research organization founded in 1984 that designs and manages early-phase, multi-center, investigator-initiated oncology clinical trials. It operates a national network of more than 100 academic and community research sites and engages over 500 researchers through ten disease-specific Clinical Trial Working Groups spanning breast, gastrointestinal, genitourinary, lymphoma, melanoma, myeloid, neuro-oncology, sarcoma, thoracic, and correlative sciences. HCRN has conducted more than 250 clinical trials, enrolled over 10,000 patients, and produced 350+ peer-reviewed publications across its 40-year history.

The organization's core technology stack includes a custom Electronic Data Capture (EDC) system with protocol-specific validation layers, the OnCore clinical trial management platform for site and investigator access, and a biorepository operating at -80°C and -140°C mechanical cryogenic storage with full chain-of-custody management. Service offerings cover the full study lifecycle: protocol and LOI development, budgeting and contracting, FDA IND submissions and regulatory maintenance, centralized SAE processing, site monitoring, correlative science management, custom EDC build, data management, and publication support. HCRN also serves as administrative headquarters for the Big Ten Cancer Research Consortium and provides trial management for the Translational Breast Cancer Research Consortium and the Bladder Cancer Genomics Consortium.

Revenue is generated through contract research services billed to pharmaceutical companies, biotech firms, government agencies, and philanthropic funders on a study-by-study basis, supplemented by donations. Pricing is not publicly disclosed and is negotiated per study. The organization is led by CEO Brian Stemme and Chairman Chris Fausel, with approximately 55 staff supporting all aspects of clinical trial management.

Name

Hoosier Cancer Research Network

Legal name

Hoosier Cancer Research Network, Inc.

Website

https://hoosiercancer.org

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

Hoosier Cancer Research Network is a nonprofit contract research organization that designs and manages early-phase, multi-center, investigator-initiated oncology clinical trials across 100+ U.S. academic and community sites for pharma, biotech, government, and philanthropic funders.

Ownership category

akta.pro rank

Product category

Oncology Clinical Research Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Clinical trial management
• Oncology research services
• Investigator-initiated trials
• Biorepository services
• Regulatory compliance support

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Clinical Trial Management Services: Contract research organization providing comprehensive study management services to pharmaceutical companies, biotech firms, government agencies, and philanthropic funders for multi-center oncology clinical trials
2. Donations and Fundraising: The organization accepts donations to support innovative research by investigators within their member network

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

Hoosier Cancer Research Network is a nonprofit contract research organization that designs and manages early-phase, multi-center, investigator-initiated oncology clinical trials. It provides comprehensive study management services — including budgeting, contracting, regulatory and IND support, custom electronic data capture, safety reporting, site monitoring, correlative science, data management, and publication support — delivered through a network of more than 100 academic and community research sites across the United States.

Product overview

Hoosier Cancer Research Network operates as a full-service nonprofit contract research organization specializing in early-phase multi-center, investigator-initiated oncology clinical trials. The offering consists of comprehensive study management services (including budgeting, contracting, regulatory support, custom EDC development, data management, and publication support) supported by a network of 100+ academic and community sites across the United States. Core offerings include the Electronic Data Capture System, Biorepository and Correlative Services, Clinical Trial Working Groups across 10 disease areas, Rapid Accrual Services, and Regulatory Compliance Services. The OnCore platform provides web-based trial management access for investigators.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Management Services End-to-end study management services for early-phase multi-center investigator-initiated oncology clinical trials, including budgeting, contracting, LOI submission, study design, regulatory and IND support, site monitoring, data management, correlative management, and publication support. Targeted at pharmaceutical and biotech sponsors, government agencies, philanthropic funders, and academic collaborators.
• Electronic Data Capture (EDC) System Customizable web-based electronic data capture system with multiple layers of data validation, protocol-specific data exports, and high-quality data consistency. Delivered as part of trial management engagements for sponsor-investigators and member sites.
• Biorepository and Correlative Services Storage and management of biospecimens shipped from consented patients, including study-specific correlative laboratory manuals, sample collection kits, complete chain of custody management, dedicated correlative managers, and cryogenic storage in -80 and -140 degree mechanical freezers.
• Rapid Accrual Services Site feasibility assessments identifying optimal sites across the network of 100+ academic and community sites, dedicated project management for study engagement, and IRB-approved communications for web, social media, and advocacy groups to accelerate patient enrollment.
• Regulatory Compliance Services FDA submission and maintenance support including IND applications, annual reports, amendments, MedWatch reports, centralized serious adverse event (SAE) processing with reporting to funders and applicable authorities, and data and safety monitoring coordination.

Quantifiable outcome

• More than 250 clinical trials conducted since 1984
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and major.

• Big Ten Cancer Research ConsortiumcoreStrategic or Co-development PartnerHCRN serves as administrative headquarters for the Big Ten Cancer Research Consortium, providing centralized management and coordination for the consortium's collaborative oncology research efforts across Big Ten universities.
• Translational Breast Cancer Research Consortium (TBCRC)coreStrategic or Co-development PartnerHCRN provides trial management and support services for the Translational Breast Cancer Research Consortium, facilitating multi-center breast cancer clinical trials and translational research studies.
• Bladder Cancer Genomics ConsortiumcoreStrategic or Co-development PartnerHCRN developed and manages a genomically driven sample collection study for the Bladder Cancer Genomics Consortium, supporting research into bladder cancer genetics and treatment outcomes.
• Pharmaceutical CompaniesmajorStrategic or Co-development PartnerIndustry funders including pharmaceutical and biotech companies that provide funding and collaboration for investigator-initiated clinical trials conducted through HCRN's network.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Medpace Holdings: Mid-size global CRO with a strong oncology franchise and full-service clinical trial management. Comparable as an oncology-focused clinical trial operator, but operates as a commercial (for-profit) entity with broader geographic reach than HCRN.

Broad incumbents

• ICON plc: Global CRO with significant oncology clinical operations and bioanalytical lab services. Comparable in providing multi-site oncology trial management, but as a commercial enterprise with global reach that HCRN cannot match.
• IQVIA: Largest global CRO with extensive oncology trial operations and technology platforms. Comparable as a clinical trial service provider to oncology sponsors, though operates at vastly larger scale and with broader service scope than HCRN.

Direct peers

• Children's Oncology Group: NCI-supported cooperative group dedicated to pediatric cancer clinical trials across 200+ sites. Comparable nonprofit, multi-center trial network model to HCRN, although focused on pediatric rather than adult oncology.
• Big Ten Cancer Research Consortium: Oncology research consortium of Big Ten universities for which HCRN serves as administrative headquarters. Direct peer in structure — academic multi-institution oncology trial network — though HCRN also operates it, making the relationship both partner and operational analog.
• ECOG-ACRIN Cancer Research Group: NCI cooperative group conducting multi-center cancer treatment, imaging, and prevention trials. Comparable model — nonprofit, site-network-based, investigator-initiated oncology research — and a direct competitor for sponsor trial placements.
• Alliance for Clinical Trials in Oncology: NCI cooperative group formed from the merger of CALGB, ACOSOG, and NCCTG. Operates a multi-center oncology trial network with academic and community sites, directly comparable to HCRN's structure.
• Translational Breast Cancer Research Consortium (TBCRC): Multi-institutional breast cancer clinical trials consortium for which HCRN provides operational management. Operates a similar academic-community trial model focused on translational breast cancer research, closely comparable in structure and mission.
• NRG Oncology: NCI-sponsored cooperative group running multi-center oncology clinical trials across U.S. sites. Directly comparable to HCRN as a nonprofit, academic-community oncology trial network, though larger in scope and NCI-funded.
• SWOG Cancer Research Network: One of the largest NCI-funded cooperative groups, running multi-site oncology clinical trials with academic and community sites. Closely comparable structure and mission to HCRN's investigator-initiated trial model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/hoosiercancer
• YouTubeyoutube.com/channel/UCFake
• Facebookfacebook.com/HoosierCancerResearchNetwork
• LinkedInlinkedin.com/company/hoosier-cancer-research-network
• Instagraminstagram.com/hoosiercancer

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hoosier Cancer Research Network